Treatment of steatotic liver disease associated with metabolic dysfunction
TW202635332APending Publication Date: 2026-09-01CARMOT THERAPEUTICS INC +2
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- TW114145407
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2025-10-15
- Filing Date
- 2025-11-20
- Publication Date
- 2026-09-01
Smart Images
Figure TWG2TA001074725_001 
Figure TWG2TA001074725_002 
Figure TWG2TA001074725_003
Abstract
The present disclosure provides methods of treating a steatotic liver disease associated with metabolic dysfunction, such as metabolic dysfunction-associated steatohepatitis (MASH), metabolic dysfunction-associated fatty livers disease (MAFLD), or metabolic dysfunction-associated steatotic liver disease (MASLD). The treatment comprises administration of a dual GLP-1 receptor and GIP receptor agonist.
Need to check novelty before this filing date? Find Prior Art